Subconjunctival injection of 100 mg of aztreonam in rabbits with Pseudomonas aeruginosa endophthalmitis produced transiently high antibiotic concentrations in most intraocular sites. Concentrations of approximately 2.5 ,ug/ml were achieved in the vitreous humor 15 min after injection and persisted for 6 h. Repeated intramuscular injections in dosages of 25 mg/kg every 4 h resulted in drug concentrations in the vitreous humor of 2.4 ,ug/ml in infected eyes. These levels might be adequate for the treatment of intraocular infections caused by highly susceptible organisms. Direct intravitreal injection of 100 ,ug of aztreonam in normal rabbit eyes produced an estimated peak concentration in the vitreous humor of 62 ,ug/ml, with a half-life of 7.5 h, which declined to 6 ,ug/ml by 48 h. The pharmacokinetic indices suggest that, like other 1-lactam antibiotics, aztreonam is eliminated from the vitreous humor by the retinal route. This novel antibiotic warrants further study of its efficacy and toxicity to determine whether it may be a useful alternative to the aminoglycosides for selected cases of ocular infection.
Subconjunctival injection of 100 mg of aztreonam in rabbits with Pseudomonas aeruginosa endophthalmitis produced transiently high antibiotic concentrations in most intraocular sites. Concentrations of approximately 2.5 ,ug/ml were achieved in the vitreous humor 15 min after injection and persisted for 6 h. Repeated intramuscular injections in dosages of 25 mg/kg every 4 h resulted in drug concentrations in the vitreous humor of 2.4 ,ug/ml in infected eyes. These levels might be adequate for the treatment of intraocular infections caused by highly susceptible organisms. Direct intravitreal injection of 100 ,ug of aztreonam in normal rabbit eyes produced an estimated peak concentration in the vitreous humor of 62 ,ug/ml, with a half-life of 7.5 h, which declined to 6 ,ug/ml by 48 h. The pharmacokinetic indices suggest that, like other 1-lactam antibiotics, aztreonam is eliminated from the vitreous humor by the retinal route. This novel antibiotic warrants further study of its efficacy and toxicity to determine whether it may be a useful alternative to the aminoglycosides for selected cases of ocular infection.
Aztreonam, formerly known as azthreonam (SQ 26, 776) , is a novel monocyclic antibiotic (9) . It has excellent activity against members of the family Enterobacteriaceae, inhibiting 50%o of isolates of most species at concentrations of s2 p,g/ml. Its potency in this regard is similar to that of the aminoglycosides (5 (4, 6) . Blood was drawn, and the animals were killed 3, 6, 24, and 48 h after injection (six to seven eyes per interval). The eyes were immediately removed for antibiotic assay.
Assay methods. The aqueous and vitreous humors were aspirated and set aside. Antibiotic levels in ocular tissues were determined by the trephine-disk method (10) . The cornea was removed, and three specimens (superior, temporal, and nasal) were excised with a 6-mm trephine. The iris was cut into four segments (superior, inferior, temporal, and nasal). The retina was dissected from the eye as a single unit. The sclera and choroid were cut into four quadrants (superior, inferior, temporal, and nasal). The choroid from each quadrant was gently scraped from the sclera. A 6-mm disk was trephined from each scleral quadrant.
These tissue specimens were promptly weighed and placed on Trypticase soy agar plates (BBL Microbiology Systems, Cockeysville, Md.) seeded with a test organism. For aztreonam, the test organism used was an Escherichia coli strain furnished by The Squibb Institute; for gentamicin, Bacillus subtilis ATCC 6633 was used. Antibiotic standards, prepared in the same solutions as those used to dilute the drugs for injection, were absorbed onto filter paper disks 6.35 mm in diameter (Schleicher & Schuell, Keene, N.H.). Assay plates were incubated at 37°C, and the zones of inhibition were nmeasured after 18 h. The inferred concentration was multipled by a correction factor based upon the ratio of the fluid content of the filter paper disks to that of the tissue sample. Studies of radiolabeled penicillin G, cefamandole, and gentamicin have shown the method to be reproducible and accurate to within 13% of the concentration measured by simultaneous radioactive assay (10) . One exception is gentamicin, which binds to pigmented tissues, 1000--ac, namely, iris and choroid (10) . The lowest concentrations which could be reliably read were 0.1 to 0.2 ,ug/g for both aztreonam and gentamicin.
Aqueous humor, vitreous humor, and serum were assayed by the agar diffusion method after absorption onto filter paper disks. The test organisms were the same as those used for tissues. Standards for the aqueous and vitreous humor were prepared in the same solutions as those used to dilute the drugs for injection, whereas serum standards were prepared in normal rabbit serum. The lower limit of sensitivity of the assay in ocular fluids or serum was 0.1 to 0.2 ,ug/ml for both drugs.
RESULTS
Subconjunctival injection. Table 1 shows the (Table 1) . Drug levels in ocular tissues 15 min after injection were disproportionately high, presumably because the very large zones of inhibition were beyond the range of accuracy of the assay. The 20-mg dose of gentamicin and the 100-mg dose of aztreonam produced similar concentrations in the cornea and the vitreous humor 6 h after injection (Fig.  1) . The half-lives of both antibiotics in the cornea, aqueous humor, and retina for the interval of 2 to 6 h after injection were between 1 and 2 h. Intramuscular injections. The mean (± standard deviation) peak level of drug in serum after the first intramuscular injection of 25 mg of aztreonam per kg was 85 ± 9 ,ug/ml. In contrast, after injection 6, the mean peak drug level in serum was only 23 ± 10 ,ug/ml. In separate experiments, we established that the decline in serum levels was not due to instability of the drug in solution or related to repetitive injections in the same site or to induction of elimination mechanisms, insofar as substituting penicillin G in injections 2 through 5 yielded the same phenomenon. Indeed, penicillin G given for six doses produced similar findings. The pigmented breed of rabbits we used appeared to be much more nervous at first handling than albino strains that we have studied in the past. Overall, it seems most likely that the difference in drug levels in serum was due to intense vasoconstriction during the first injection. However, the halflife of aztreonam in serum was approximately 1 h after doses 1 and 6.
The mean peak concentrations of' aztreonam after six intramuscular injections were approximately 6.5 p,g/g in the superior cornea and 6.5 ,ug/ml in the aqueous humor. In contrast, mean peak concentrations were 3.5 ,g/g in the retina and 2.4 ,ug/ml in the vitreous humor. The level in the vitreous humor was similar to that produced by subconjunctival injection of 100 mg of aztreonam (Fig. 1) steadily but were still 6 ,ug/ml after 48 h (Fig. 2) . Extrapolation of the vitreous humor concentrations to time zero yielded a hypothetical initial concentration of 62 pug/ml, corresponding to a distribution volume in the vitreous humor of 1.6 ml. The half-life of aztreonam in the vitreous humor, calculated by regression analysis, was 7.5 h. Drug concentrations in the aqueous humor were lower than those in the vitreous humor at all intervals studied (Fig. 2) .
DISCUSSION
Aztreonam has excellent activity against members of the family Enterobacteriaceae, inhibiting 50% of the isolates of the most commonly encountered species at concentrations of <2 ,ug/ml. This drug offers promise as an alternative to aminoglycosides in treating eye infections caused by gram-negative bacilli.
Subconjunctival injection of 20 mg of aztreonam into rabbits with infected eyes produced transiently high concentrations in anterior ocular sites (cornea and aqueous humor) which declined rapidly to levels of <2 ,ug/ml within 6 h. Gentamicin, given in the same dosage, produced higher levels than aztreonam in anterior ocular sites, particularly the cornea. In contrast, gentamicin produced lower levels than did aztreonam in pigmented tissues, i.e., iris and choroid. This difference is presumably related to the fact that gentamicin, but not ,-lactam drugs, is bound tightly to pigmented ocular tissues and is not readily detectable by agar diffusion bioassay (2, 10) . The intraocular concentrations of gentamicin in this study were very similar to those measured in a previous experiment in which the same subconjunctival dosage was used in rabbits with infected eyes (3).
Gentamicin, when given by the subconjunctival route to humans, is usually given in a dosage of 20 to 40 mg. In contrast, P-lactam antibiotics are usually administered in a dosage of 100 mg.
Preliminary studies in our laboratory (unpublished data) indicated that aztreonam was well tolerated when given daily by subconjunctival injection in this dosage to rabbits. Accordingly, we examined the intraocular penetration of this higher dosage of aztreonam. The resulting concentrations in ocular tissues and fluids were 5-to 10-fold higher than those produced by 20 mg of aztreonam. However, levels in the cornea, aqueous humor, and vitreous humor after 1 h were not markedly different from those produced by the 20-mg dose of gentamicin. Not surprisingly, concentrations of either drug in ocular tissues were highest in segments nearest the site of subconjunctival injection (1) .
Repeated intramuscular injections of 25 mg of aztreonam per kg produced peak drug concentrations in serum of 23 to 85 ,ug/ml and peak drug levels in the vitreous humor of about 2.4 ,ug/ml.
The latter concentrations were in the same range as those produced by injection of 100 mg of aztreonam subconjunctivally. Thus, both methods of administration resulted in aztreonam levels in the vitreous humor which might be active against selected gram-negative enteric bacilli. In a previous study, moxalactam given in a dosage of 50 mg/kg intramuscularly every 4 h, i.e., twice the dosage used in this study, produced peak levels in the vitreous humor of about 6 ,ug/ml in infected eyes (7) . Thus, the intraocular penetration of moxalactam and aztreonam appear to be fairly similar.
Intravitreal injection of 100 ,ug of aztreonam in normal rabbit eyes produced an extrapolated peak concentration at zero time of 62 9g/ml, corresponding to a distribution volume in the vitreous humor of 1.6 ml, which is in the usual range in this species (1, 8) . The half-life of aztreonam in the vitreous humor, 7.5 h, was slightly longer than those reported for methicillin (6 h), penicillin G (5 h), and carbenicillin (5 h) in normal rabbit eyes (4, 8) . Levels of aztreonam in the aqueous humor were only 3 to 4% of the corresponding concentrations in the vitreous humor after intravitreal injection. This relatively short half-life and low aqueous/vitreous concentration ratio suggest that aztreonam leaves the vitreous humor via the retinal route of transport (1, 8) . In contrast, drugs such as the aminoglycosides, which exit via the anterior route (anterior chamber and canal of Schlemm), exhibit a long half-life and high aqueous/vitreous concentration ratios (1, 4, 6, 8) .
In summary, these studies indicate that subconjunctival injection of aztreonam in infected rabbit eyes produces high but short-lived peak levels in most ocular sites and modest levels in the vitreous humor (approximately 2.5 xg/ml). Repeated intramuscular injections of 25 mg/kg produced drug levels in the aqueous humor and cornea of about 6.5 p1g/ml (or ,Lg/g) and concentrations in the vitreous humor of just above 2 p.g/ml. These levels in the vitreous humor might be sufficient for treatment of endophthalmitis due to highly susceptible gram-negative bacilli but inadequate for other strains. Direct intravitreal injection of aztreonam resulted in high concentrations in the vitreous humor, and pharmacokinetic indices suggest that the drug is eliminated from the eye via the retinal route.
